In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells

Myocardial infarction (MI) causes an extensive loss of heart muscle cells and leads to congestive heart disease (CAD), the leading cause of mortality and morbidity worldwide. Mesenchymal stromal cell- (MSC-) based cell therapy is a promising option to replace invasive interventions. However the opti...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Szaraz, Matthew Librach, Leila Maghen, Farwah Iqbal, Tanya A. Barretto, Shlomit Kenigsberg, Andrée Gauthier-Fisher, Clifford L. Librach
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/7513252
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563629461864448
author Peter Szaraz
Matthew Librach
Leila Maghen
Farwah Iqbal
Tanya A. Barretto
Shlomit Kenigsberg
Andrée Gauthier-Fisher
Clifford L. Librach
author_facet Peter Szaraz
Matthew Librach
Leila Maghen
Farwah Iqbal
Tanya A. Barretto
Shlomit Kenigsberg
Andrée Gauthier-Fisher
Clifford L. Librach
author_sort Peter Szaraz
collection DOAJ
description Myocardial infarction (MI) causes an extensive loss of heart muscle cells and leads to congestive heart disease (CAD), the leading cause of mortality and morbidity worldwide. Mesenchymal stromal cell- (MSC-) based cell therapy is a promising option to replace invasive interventions. However the optimal cell type providing significant cardiac regeneration after MI is yet to be found. The aim of our study was to investigate the cardiomyogenic differentiation potential of first trimester human umbilical cord perivascular cells (FTM HUCPVCs), a novel, young source of immunoprivileged mesenchymal stromal cells. Based on the expression of cardiomyocyte markers (cTnT, MYH6, SIRPA, and CX43) FTM and term HUCPVCs achieved significantly increased cardiomyogenic differentiation compared to bone marrow MSCs, while their immunogenicity remained significantly lower as indicated by HLA-A and HLA-G expression and susceptibility to T cell mediated cytotoxicity. When applying aggregate-based differentiation, FTM HUCPVCs showed increased aggregate formation potential and generated contracting cells within 1 week of coculture, making them the first MSC type with this ability. Our results indicate that young FTM HUCPVCs have superior cardiomyogenic potential coupled with beneficial immunogenic properties when compared to MSCs of older tissue sources, suggesting that in vitro predifferentiation could be a potential strategy to increase their effectiveness in vivo.
format Article
id doaj-art-3a8db5f1f4e64135960eb3487b175ae5
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-3a8db5f1f4e64135960eb3487b175ae52025-02-03T01:12:58ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/75132527513252In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like CellsPeter Szaraz0Matthew Librach1Leila Maghen2Farwah Iqbal3Tanya A. Barretto4Shlomit Kenigsberg5Andrée Gauthier-Fisher6Clifford L. Librach7Create Fertility Centre, Toronto, ON, M5G 1N8, CanadaCreate Fertility Centre, Toronto, ON, M5G 1N8, CanadaCreate Fertility Centre, Toronto, ON, M5G 1N8, CanadaCreate Fertility Centre, Toronto, ON, M5G 1N8, CanadaCreate Fertility Centre, Toronto, ON, M5G 1N8, CanadaCreate Fertility Centre, Toronto, ON, M5G 1N8, CanadaCreate Fertility Centre, Toronto, ON, M5G 1N8, CanadaCreate Fertility Centre, Toronto, ON, M5G 1N8, CanadaMyocardial infarction (MI) causes an extensive loss of heart muscle cells and leads to congestive heart disease (CAD), the leading cause of mortality and morbidity worldwide. Mesenchymal stromal cell- (MSC-) based cell therapy is a promising option to replace invasive interventions. However the optimal cell type providing significant cardiac regeneration after MI is yet to be found. The aim of our study was to investigate the cardiomyogenic differentiation potential of first trimester human umbilical cord perivascular cells (FTM HUCPVCs), a novel, young source of immunoprivileged mesenchymal stromal cells. Based on the expression of cardiomyocyte markers (cTnT, MYH6, SIRPA, and CX43) FTM and term HUCPVCs achieved significantly increased cardiomyogenic differentiation compared to bone marrow MSCs, while their immunogenicity remained significantly lower as indicated by HLA-A and HLA-G expression and susceptibility to T cell mediated cytotoxicity. When applying aggregate-based differentiation, FTM HUCPVCs showed increased aggregate formation potential and generated contracting cells within 1 week of coculture, making them the first MSC type with this ability. Our results indicate that young FTM HUCPVCs have superior cardiomyogenic potential coupled with beneficial immunogenic properties when compared to MSCs of older tissue sources, suggesting that in vitro predifferentiation could be a potential strategy to increase their effectiveness in vivo.http://dx.doi.org/10.1155/2016/7513252
spellingShingle Peter Szaraz
Matthew Librach
Leila Maghen
Farwah Iqbal
Tanya A. Barretto
Shlomit Kenigsberg
Andrée Gauthier-Fisher
Clifford L. Librach
In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells
Stem Cells International
title In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells
title_full In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells
title_fullStr In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells
title_full_unstemmed In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells
title_short In Vitro Differentiation of First Trimester Human Umbilical Cord Perivascular Cells into Contracting Cardiomyocyte-Like Cells
title_sort in vitro differentiation of first trimester human umbilical cord perivascular cells into contracting cardiomyocyte like cells
url http://dx.doi.org/10.1155/2016/7513252
work_keys_str_mv AT peterszaraz invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells
AT matthewlibrach invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells
AT leilamaghen invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells
AT farwahiqbal invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells
AT tanyaabarretto invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells
AT shlomitkenigsberg invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells
AT andreegauthierfisher invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells
AT cliffordllibrach invitrodifferentiationoffirsttrimesterhumanumbilicalcordperivascularcellsintocontractingcardiomyocytelikecells